Pharmacological Strategies and Recent Advancement in Nano-Drug Delivery for Targeting Asthma

• Published in: Life (Basel, Switzerland) Vol. 12; no. 4; p. 596
• Main Author: Ahmad, Aftab
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 18-04-2022; MDPI
• Subjects: Asthma; Biocompatibility; Cancer; Dendrimers; Drug delivery; Drug delivery systems; Drug development; Drugs; Health hazards; Illnesses; liposome; Lungs; Medical research; Medicine; Micelles; nano-drug delivery; Nanomaterials; Nanoparticles; Nanotechnology; Polymers; Quality of life; Quantum dots; Review; Steroids; Transportation systems; asthma; nano-drug delivery; polymers; dendrimers; liposome
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life12040596

With a high prevalence globally, asthma is a severe hazard to human health, as well as an economic and social burden. There are now novel therapies available for asthma with the use of nanotechnology. Recent developments in nanoscience and medicine have encouraged the creation of inhalable nanomedicines that can enhance the efficacy, patient compliance, and life quality for sufferers of asthma. Nanocarriers for asthma therapy, including liposomes, micelles, polymers, dendrimers, and inorganics, are presented in depth in this study as well as the current research status of these nanocarriers. Aerosolized nanomaterial-based drug transport systems are currently being developed, and some examples of these systems, as well as prospective future paths, are discussed. New research subjects include nano-modification of medicines and the development of innovative nano-drugs. Clinical experiments have proven that nanocarriers are both safe and effective. Before nanotherapy can be applied in clinical practice, several obstacles must be addressed. We look at some of the most recent research discoveries in the subject of nanotechnology and asthma therapy in this article.